{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:54:47Z","timestamp":1788382487256,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40121-026-01348-x","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:46:39Z","timestamp":1777707999000},"page":"1633-1647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Infections Caused by Fusobacterium Species: Microbiology, Clinical Syndromes and Management: A Narrative Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Michal","family":"Paret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Katzenellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ili","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-9791","authenticated-orcid":false,"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"2","key":"1348_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s15010-013-0564-2","volume":"42","author":"E Pett","year":"2014","unstructured":"Pett E, Saeed K, Dryden M. Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection. 2014;42(2):363\u201370. https:\/\/doi.org\/10.1007\/s15010-013-0564-2.","journal-title":"Infection"},{"issue":"4","key":"1348_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/S15010-015-0871-X\/TABLES\/2","volume":"44","author":"E Denes","year":"2016","unstructured":"Denes E, Barraud O. Fusobacterium nucleatum infections: clinical spectrum and bacteriological features of 78 cases. Infection. 2016;44(4):475\u201381. https:\/\/doi.org\/10.1007\/S15010-015-0871-X\/TABLES\/2.","journal-title":"Infection"},{"issue":"4","key":"1348_CR3","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s15010-024-02462-z","volume":"53","author":"D Hettle","year":"2025","unstructured":"Hettle D, Thompson A, Akpan E, Beckley G, Williams OM. Clinical and microbiological features of Fusobacterium species bacteraemia: a multi-centre UK-based retrospective descriptive study. Infection. 2025;53(4):1527\u201330. https:\/\/doi.org\/10.1007\/s15010-024-02462-z. (Epub 2025 Jan 16. PMID: 39821737.).","journal-title":"Infection"},{"issue":"2","key":"1348_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60020248","volume":"60","author":"A Khan","year":"2024","unstructured":"Khan A, Alzghoul H, Khan AA, Allada G, Gronquist JM, Pak J, et al. Epidemiology and clinical outcomes of Fusobacterium infections: a six-year retrospective study. Medicina (Kaunas). 2024;60(2):248. https:\/\/doi.org\/10.3390\/medicina60020248. (PMID: 38399536; PMCID: PMC10890494.).","journal-title":"Medicina (Kaunas)"},{"key":"1348_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-264","volume":"13","author":"K Afra","year":"2013","unstructured":"Afra K, Laupland K, Leal J, Lloyd T, Gregson D. Incidence, risk factors, and outcomes of Fusobacterium species bacteremia. BMC Infect Dis. 2013;13:1. https:\/\/doi.org\/10.1186\/1471-2334-13-264.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1348_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/S12879-017-2548-9","volume":"17","author":"D Jayasimhan","year":"2017","unstructured":"Jayasimhan D, Wu L, Huggan P. Fusobacterial liver abscess: a case report and review of the literature. BMC Infect Dis. 2017;17(1):440. https:\/\/doi.org\/10.1186\/S12879-017-2548-9.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1348_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/GUT.2009.191320","volume":"60","author":"A Swidsinski","year":"2011","unstructured":"Swidsinski A, D\u00f6rffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum\/necrophorum. Gut. 2011;60(1):34\u201340. https:\/\/doi.org\/10.1136\/GUT.2009.191320.","journal-title":"Gut"},{"key":"1348_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.ANAEROBE.2018.01.008","volume":"50","author":"EL Vander Haar","year":"2018","unstructured":"Vander Haar EL, So J, Gyamfi-Bannerman C, Han YW. Fusobacterium nucleatum and adverse pregnancy outcomes: epidemiological and mechanistic evidence. Anaerobe. 2018;50:55. https:\/\/doi.org\/10.1016\/J.ANAEROBE.2018.01.008.","journal-title":"Anaerobe"},{"issue":"8","key":"1348_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/PATHOGENS14080829\/S1","volume":"14","author":"P Ioannou","year":"2025","unstructured":"Ioannou P, Mourati E, Thalasseli Kazali S, Bali C, Baliou S, Samonis G. Infective endocarditis by Fusobacterium species\u2014a systematic review. Pathogens. 2025;14(8):829. https:\/\/doi.org\/10.3390\/PATHOGENS14080829\/S1.","journal-title":"Pathogens"},{"key":"1348_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2024.102934","author":"G Franceschi","year":"2025","unstructured":"Franceschi G, Marchi M, Zambianchi F, Meschiari M, Mussini C, Bedini A. Fusobacterium necrophorum septic arthritis of the hip: a case-report and literature review. Anaerobe. 2025. https:\/\/doi.org\/10.1016\/j.anaerobe.2024.102934.","journal-title":"Anaerobe"},{"issue":"3","key":"1348_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10096-023-04734-2","volume":"43","author":"N Mori","year":"2024","unstructured":"Mori N, Nakamura A, Hirai J, et al. Clinical characteristics and antimicrobial susceptibility of Fusobacterium species isolated over 10 years at a Japanese university hospital. Eur J Clin Microbiol Infect Dis. 2024;43(3):423\u201333. https:\/\/doi.org\/10.1007\/s10096-023-04734-2.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4 April","key":"1348_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0266610","volume":"17","author":"SJ Lee","year":"2022","unstructured":"Lee SJ, Baek YJ, Kim JN, et al. Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen. PLoS ONE. 2022;17(4 April):1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0266610.","journal-title":"PLoS ONE"},{"key":"1348_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mib.2014.11.013","volume":"23","author":"YW Han","year":"2015","unstructured":"Han YW. Fusobacterium nucleatum: A commensal-turned pathogen. Curr Opin Microbiol. 2015;23:141\u20137. https:\/\/doi.org\/10.1016\/j.mib.2014.11.013.","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"1348_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jmii.2020.03.027","volume":"53","author":"WS Lee","year":"2020","unstructured":"Lee WS, Jean SS, Chen FL, Hsieh SM, Hsueh PR. Lemierre\u2019s syndrome: a forgotten and re-emerging infection. J Microbiol Immunol Infect. 2020;53(4):513\u20137. https:\/\/doi.org\/10.1016\/j.jmii.2020.03.027.","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"1348_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3343\/ALM.2022.42.2.188","volume":"42","author":"M Kim","year":"2022","unstructured":"Kim M, Yun SY, Lee Y, Lee H, Yong D, Lee K. Clinical differences in patients infected with Fusobacterium and antimicrobial susceptibility of Fusobacterium isolates recovered at a tertiary-care hospital in Korea. Ann Lab Med. 2022;42(2):188\u201395. https:\/\/doi.org\/10.3343\/ALM.2022.42.2.188.","journal-title":"Ann Lab Med"},{"issue":"1","key":"1348_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/S10620-014-3390-1","volume":"60","author":"E Allen-Vercoe","year":"2014","unstructured":"Allen-Vercoe E. Fusobacterium varium in ulcerative colitis: Is it population-based? Dig Dis Sci. 2014;60(1):7\u20138. https:\/\/doi.org\/10.1007\/S10620-014-3390-1.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"1348_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/S10096-016-2612-1\/TABLES\/1","volume":"35","author":"T Stergiopoulou","year":"2016","unstructured":"Stergiopoulou T, Walsh TJ. Fusobacterium necrophorum otitis and mastoiditis in infants and young toddlers. Eur J Clin Microbiol Infect Dis. 2016;35(5):735\u201340. https:\/\/doi.org\/10.1007\/S10096-016-2612-1\/TABLES\/1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"1348_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/INF.0b013e318169035e","volume":"27","author":"A Le Monnier","year":"2008","unstructured":"Le Monnier A, Jamet A, Carbonnelle E, et al. Fusobacterium necrophorum middle ear infections in children and related complications: Report of 25 cases and literature review. Pediatr Infect Dis J. 2008;27(7):613\u20137. https:\/\/doi.org\/10.1097\/INF.0b013e318169035e.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1348_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/INF.0000000000002021","volume":"38","author":"M Gelbart","year":"2019","unstructured":"Gelbart M, Bilavsky E, Chodick G, Raveh E, Levy I, Ashkenazi-Hoffnung L. Fusobacterium necrophorum as an emerging pathogen of acute mastoiditis. Pediatr Infect Dis J. 2019;38(1):12\u20135. https:\/\/doi.org\/10.1097\/INF.0000000000002021.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1348_CR20","doi-asserted-by":"publisher","DOI":"10.3171\/2025.8.FOCUS25679","volume":"59","author":"M Stefani","year":"2025","unstructured":"Stefani M, Beccaria K, Galland A, et al. Ear and nose-related intracranial empyema in children: a 9-year cohort study from a tertiary referral center. Neurosurg Focus. 2025;59(5):E6. https:\/\/doi.org\/10.3171\/2025.8.FOCUS25679.","journal-title":"Neurosurg Focus"},{"issue":"2","key":"1348_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/coa.13478","volume":"45","author":"A Coudert","year":"2020","unstructured":"Coudert A, Fanchette J, Regnier G, et al. Fusobacterium necrophorum, a major provider of sinus thrombosis in acute mastoiditis: A retrospective multicentre paediatric study. Clin Otolaryngol. 2020;45(2):182\u20139. https:\/\/doi.org\/10.1111\/coa.13478.","journal-title":"Clin Otolaryngol"},{"key":"1348_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114672","author":"E Chebib","year":"2025","unstructured":"Chebib E, Ok V, Cohen JF, et al. Changes in clinical and microbiological characteristics of acute mastoiditis in children: a comparative study between 2001-2008 and 2021-2024. J Pediatr. 2025. https:\/\/doi.org\/10.1016\/j.jpeds.2025.114672.","journal-title":"J Pediatr"},{"key":"1348_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/J.ANAEROBE.2016.09.006","volume":"42","author":"K Holm","year":"2016","unstructured":"Holm K, Bank S, Nielsen H, Kristensen LH, Prag J, Jensen A. The role of Fusobacterium necrophorum in pharyngotonsillitis \u2013 A review. Anaerobe. 2016;42:89\u201397. https:\/\/doi.org\/10.1016\/J.ANAEROBE.2016.09.006.","journal-title":"Anaerobe"},{"issue":"7","key":"1348_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/J.1469-0691.2007.01719.X","volume":"13","author":"A Jensen","year":"2007","unstructured":"Jensen A, Hagelskj\u00e6r Kristensen L, Prag J. Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR. Clin Microbiol Infect. 2007;13(7):695\u2013701. https:\/\/doi.org\/10.1111\/J.1469-0691.2007.01719.X.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1348_CR25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/S10096-025-05156-Y","volume":"44","author":"E Lindberg","year":"2025","unstructured":"Lindberg E, Hermansson A, Nygren D, Gisselsson-Sol\u00e9n M. Association between clinical outcome and microbiological findings in peritonsillar abscess - an observational study. Eur J Clin Microbiol Infect Dis. 2025;44(8):1925\u201333. https:\/\/doi.org\/10.1007\/S10096-025-05156-Y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1348_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13879","author":"G Coutinho","year":"2021","unstructured":"Coutinho G, Duerden M, Sessa A, Caretta-Barradas S, Altiner A. Worldwide comparison of treatment guidelines for sore throat. Int J Clin Pract. 2021. https:\/\/doi.org\/10.1111\/ijcp.13879.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"1348_CR27","doi-asserted-by":"publisher","first-page":"e1428","DOI":"10.1093\/CID\/CIAC736","volume":"76","author":"D Nygren","year":"2023","unstructured":"Nygren D, Wasserstrom L, Holm K, Torisson G. Associations between findings of Fusobacterium necrophorum or \u03b2-hemolytic streptococci and complications in pharyngotonsillitis\u2014a registry-based study in southern Sweden. Clin Infect Dis. 2023;76(3):e1428\u201335. https:\/\/doi.org\/10.1093\/CID\/CIAC736.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1348_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.CMI.2023.08.016","volume":"30","author":"J Bodilsen","year":"2024","unstructured":"Bodilsen J, D\u2019Alessandris QG, Humphreys H, et al. European Society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect. 2024;30(1):66\u201389. https:\/\/doi.org\/10.1016\/J.CMI.2023.08.016.","journal-title":"Clin Microbiol Infect"},{"key":"1348_CR29","unstructured":"Aaron SL, DeBlois KW. Acute necrotizing ulcerative gingivitis. StatPearls. Published online July 20, 2023. https:\/\/www-ncbi-nlm-nih-gov.sheba.idm.oclc.org\/books\/NBK562243\/. Accessed 9 April 2025"},{"issue":"6","key":"1348_CR30","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/00005792-200211000-00006","volume":"81","author":"JA Chirinos","year":"2002","unstructured":"Chirinos JA, Lichtstein DM, Garcia J, Tamariz LJ. The evolution of Lemierre syndrome: report of 2 cases and review of the literature. Medicine (Baltimore). 2002;81(6):458\u201365. https:\/\/doi.org\/10.1097\/00005792-200211000-00006.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1348_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S1473-3099(12)70089-0","volume":"12","author":"K Kuppalli","year":"2012","unstructured":"Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre\u2019s syndrome due to Fusobacterium necrophorum. Lancet Infect Dis. 2012;12(10):808\u201315. https:\/\/doi.org\/10.1016\/S1473-3099(12)70089-0.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1348_CR32","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1128\/CMR.00011-07\/FORMAT\/EPUB","volume":"20","author":"T Riordan","year":"2007","unstructured":"Riordan T. Human infection with Fusobacterium necrophorum (necrobacillosis), with a focus on Lemierre\u2019s syndrome. Clin Microbiol Rev. 2007;20(4):622\u201359. https:\/\/doi.org\/10.1128\/CMR.00011-07\/FORMAT\/EPUB.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"1348_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/joim.13114","volume":"289","author":"L Valerio","year":"2021","unstructured":"Valerio L, Zane F, Sacco C, et al. Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases. J Intern Med. 2021;289(3):325\u201339. https:\/\/doi.org\/10.1111\/joim.13114.","journal-title":"J Intern Med"},{"issue":"8","key":"1348_CR34","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/LARY.20542","volume":"119","author":"PD Karkos","year":"2009","unstructured":"Karkos PD, Asrani S, Karkos CD, et al. Lemierre\u2019s syndrome: a systematic review. Laryngoscope. 2009;119(8):1552\u20139. https:\/\/doi.org\/10.1002\/LARY.20542.","journal-title":"Laryngoscope"},{"issue":"5","key":"1348_CR35","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/S15010-025-02489-W","volume":"53","author":"M Frehner","year":"2025","unstructured":"Frehner M, Fumagalli RM, Brugger SD, et al. Microbiological diversity among patients with Lemierre syndrome and clinical implications: an individual patient-level analysis. Infection. 2025;53(5):1745\u201354. https:\/\/doi.org\/10.1007\/S15010-025-02489-W.","journal-title":"Infection"},{"issue":"2","key":"1348_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1586\/eri.10.172","volume":"9","author":"G Dahl\u00e9n","year":"2011","unstructured":"Dahl\u00e9n G, Ebenfelt A. Necrobacillosis in humans. Expert Rev Anti Infect Ther. 2011;9(2):227\u201336. https:\/\/doi.org\/10.1586\/eri.10.172.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"62","key":"1348_CR37","first-page":"41","volume":"62","author":"SJ Eykyn","year":"1989","unstructured":"Eykyn SJ. Necrobacillosis. Scand J Infect Dis Suppl. 1989;62(62):41\u20136 (Accessed November 7, 2025.).","journal-title":"Scand J Infect Dis Suppl"},{"issue":"8","key":"1348_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF01708619","volume":"17","author":"LH Hagelskj\u00e6r","year":"1998","unstructured":"Hagelskj\u00e6r LH, Prag J, Malczynski J, Kristensen JH. Incidence and clinical epidemiology of necrobacillosis, including Lemierre\u2019s syndrome, in Denmark 1990\u20131995. 1998 178. Eur J Clin Microbiol Infect Dis. 1998;17(8):561\u20135. https:\/\/doi.org\/10.1007\/BF01708619.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"1348_CR39","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.jpag.2013.02.008","volume":"26","author":"A McKinnon","year":"2013","unstructured":"McKinnon A, Black AY, Lortie K, Fleming NA. A case of adolescent pelvic inflammatory disease caused by a rare bacterium: Fusobacterium nucleatum. J Pediatr Adolesc Gynecol. 2013;26(6):e113\u20135. https:\/\/doi.org\/10.1016\/j.jpag.2013.02.008.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"9","key":"1348_CR40","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/IBD.21606","volume":"17","author":"J Strauss","year":"2011","unstructured":"Strauss J, Kaplan GG, Beck PL, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis. 2011;17(9):1971\u20138. https:\/\/doi.org\/10.1002\/IBD.21606.","journal-title":"Inflamm Bowel Dis"},{"issue":"6-7","key":"1348_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/00365548.2011.565071","volume":"43","author":"E Nohrstr\u00f6m","year":"2011","unstructured":"Nohrstr\u00f6m E, Mattila T, Pettil\u00e4 V, et al. Clinical spectrum of bacteraemic Fusobacterium infections: from septic shock to nosocomial bacteraemia. Scand J Infect Dis. 2011;43(6\u20137):463\u201370. https:\/\/doi.org\/10.3109\/00365548.2011.565071.","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"1348_CR42","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/APM.12606","volume":"124","author":"S Bank","year":"2016","unstructured":"Bank S, Jensen A, Nielsen HM, Kristensen LH, Voldstedlund M, Prag J. Fusobacterium necrophorum findings in Denmark from 2010 to 2014 using data from the Danish microbiology database. APMIS. 2016;124(12):1087\u201392. https:\/\/doi.org\/10.1111\/APM.12606.","journal-title":"APMIS"},{"key":"1348_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2020.102165","author":"AM Almohaya","year":"2020","unstructured":"Almohaya AM, Almutairy TS, Alqahtani A, Binkhamis K, Almajid FM. Fusobacterium bloodstream infections: a literature review and hospital-based case series. Anaerobe. 2020. https:\/\/doi.org\/10.1016\/j.anaerobe.2020.102165.","journal-title":"Anaerobe"},{"issue":"4","key":"1348_CR44","first-page":"336","volume":"42","author":"CP Su","year":"2009","unstructured":"Su CP, Huang PY, Yang CC, Lee MH. Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect. 2009;42(4):336\u201342.","journal-title":"J Microbiol Immunol Infect"},{"key":"1348_CR45","doi-asserted-by":"publisher","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria. 9th ed. CLSI; 2018. CLSI document M11-ED9. https:\/\/doi.org\/10.1128\/JCM.01934-17\/SUPPL_FILE\/ZJM999095879S1.PDF","DOI":"10.1128\/JCM.01934-17\/SUPPL_FILE\/ZJM999095879S1.PDF"},{"key":"1348_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANAEROBE.2023.102717","volume":"80","author":"MD Perry","year":"2023","unstructured":"Perry MD, Vranckx K, Copsey-Mawer S, et al. First large-scale study of antimicrobial susceptibility data, and genetic resistance determinants, in Fusobacterium necrophorum highlighting the importance of continuing focused susceptibility trend surveillance. Anaerobe. 2023;80:102717. https:\/\/doi.org\/10.1016\/J.ANAEROBE.2023.102717.","journal-title":"Anaerobe"},{"key":"1348_CR47","unstructured":"EUCAST European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_50_Breakpoint_Table_01.pdf. Published online 2025:0\u201377."},{"key":"1348_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107478","volume":"65","author":"M Boattini","year":"2025","unstructured":"Boattini M, Bianco G, Bastos P. Diagnostic and epidemiological landscape of anaerobic bacteria in Europe, 2020-2023 (ANAEuROBE). Int J Antimicrob Agents. 2025;65:107478. https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107478.","journal-title":"Int J Antimicrob Agents"},{"key":"1348_CR49","unstructured":"Lemierre syndrome: Septic thrombophlebitis of the internal jugular vein - UpToDate. https:\/\/www-uptodate-com.sheba.portium.org\/contents\/lemierre-syndrome-septic-thrombophlebitis-of-the-internal-jugular-vein?search=lemierresyndrome&source=search_result&selectedTitle=1~29&usage_type=default&display_rank=1. Accessed 13 August 2025"},{"key":"1348_CR50","doi-asserted-by":"publisher","unstructured":"Garrett WS, Onderdonk AB (2019) Bacteroides, Prevotella, Porphyromonas, and Fusobacterium species (and other medically important anaerobic Gram-negative bacilli). In: Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, 9th edition: volume 1\u20132. Vol 2. Ninth edition. Elsevier Inc. pp. 2969\u20132976.e1. https:\/\/doi.org\/10.1016\/B978-0-323-48255-4.00247-2","DOI":"10.1016\/B978-0-323-48255-4.00247-2"},{"issue":"7","key":"1348_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/INF.0000000000003514","volume":"41","author":"A Hirschhorn","year":"2022","unstructured":"Hirschhorn A, Averbuch D, Michaan N, Adler A, Grisaru-Soen G. Invasive Fusobacterium infections in children: a retrospective multicenter study. Pediatr Infect Dis J. 2022;41(7):517\u201323. https:\/\/doi.org\/10.1097\/INF.0000000000003514.","journal-title":"Pediatr Infect Dis J"},{"key":"1348_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0B013E31827B4D61","author":"A Ramos","year":"2013","unstructured":"Ramos A, Berbari E, Huddleston P. Diagnosis and treatment of Fusobacterium nucleatum discitis and vertebral osteomyelitis: case report and review of the literature. Spine (Phila Pa 1976). 2013. https:\/\/doi.org\/10.1097\/BRS.0B013E31827B4D61.","journal-title":"Spine (Phila Pa 1976)"},{"key":"1348_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa585","author":"D Nygren","year":"2021","unstructured":"Nygren D, Elf J, Torisson G, Holm K. Jugular vein thrombosis and anticoagulation therapy in Lemierre\u2019s syndrome - a post hoc observational and population-based study of 82 patients. Open Forum Infect Dis. 2021. https:\/\/doi.org\/10.1093\/ofid\/ofaa585.","journal-title":"Open Forum Infect Dis"},{"key":"1348_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4538-6","author":"ME Laurencet","year":"2019","unstructured":"Laurencet ME, Rosset Zufferey S, Schrenzel J. Atypical presentation of Lemierre\u2019s syndrome: case report and literature review. BMC Infect Dis. 2019. https:\/\/doi.org\/10.1186\/s12879-019-4538-6.","journal-title":"BMC Infect Dis"},{"key":"1348_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/S12866-020-01887-4","author":"JW Huh","year":"2020","unstructured":"Huh JW, Roh TY. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis. BMC Microbiol. 2020. https:\/\/doi.org\/10.1186\/S12866-020-01887-4.","journal-title":"BMC Microbiol"},{"key":"1348_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/FCIMB.2020.00400","volume":"10","author":"J Abed","year":"2020","unstructured":"Abed J, Maalouf N, Manson AL, et al. Colon cancer-associated Fusobacterium nucleatum may originate from the oral cavity and reach colon tumors via the circulatory system. Front Cell Infect Microbiol. 2020;10:400. https:\/\/doi.org\/10.3389\/FCIMB.2020.00400.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8007","key":"1348_CR57","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera M, Minot SS, Bouzek H, et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature. 2024;628(8007):424\u201332. https:\/\/doi.org\/10.1038\/s41586-024-07182-w.","journal-title":"Nature"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01348-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:50:40Z","timestamp":1779972640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01348-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01348-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dafna Yahav declares a collaborative retrospective study with Pfizer, and an investigator-initiated study funded by Shionogi (all funding paid to the institution); Michal Paret, Guy Katzenellenbogen, Michal Stein, Ili Margalit, Tal Zilberman have nothing to disclose. Dafna Yahav is an Editorial Board Member of\n                      Infectious Diseases and Therapy\n                      . Dafna Yahav was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}